Kyoto University and McGill University, which have the world’s leading achievements in the research of genomic analysis, implement the joint Ph.D. degree program in close collaboration (Kyoto-McGill International Collaborative Program in Genomic Medicine.)
Thus, the program aims to promote high-quality education and research, which mutually supplement the characteristics of both universities and which cannot be realized at a single university, and to foster human resources who can contribute to the future development of preventive medicine.
In this program, students study the so-called bio big data, the observational data of the various molecules in vivo, such as genomes, and aim to acquire the experience and skills of highly specialized techniques of analyzing concerning research in human biology.
However, we also aim for something else; our basic philosophy is to foster leaders with broad and profound knowledge of medicine who also understand medical treatment and research from a global viewpoint. Therefore, as an admission policy, we require those who have not only the ability in genomic analysis but also a great interest in molecular biology and medical sciences, the creativity, the ability to judge and analyze profoundly, and the morality, or those whom we can expect to have those qualities. Thus, we aim to foster human resources who can lead the development of medicine as excellent researchers in genomic medicine with a strong orientation toward research.